vs
Forestar Group Inc.（FOR）与Lantheus Holdings, Inc.（LNTH）财务数据对比。点击上方公司名可切换其他公司
Lantheus Holdings, Inc.的季度营收约是Forestar Group Inc.的1.5倍（$406.8M vs $273.0M），Lantheus Holdings, Inc.净利率更高（13.3% vs 5.6%，领先7.7%），Forestar Group Inc.同比增速更快（9.0% vs 4.0%），Lantheus Holdings, Inc.自由现金流更多（$81.4M vs $-157.1M），过去两年Lantheus Holdings, Inc.的营收复合增速更高（4.9% vs -9.6%）
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Lantheus Holdings是一家全球性医疗保健企业，专注于研发、生产及商业化创新诊断显像剂与相关解决方案，产品覆盖肿瘤学、心脏病学、泌尿学等核心医疗领域，主要市场遍及北美及全球其他重点地区。
FOR vs LNTH — 直观对比
营收规模更大
LNTH
是对方的1.5倍
$273.0M
营收增速更快
FOR
高出5.0%
4.0%
净利率更高
LNTH
高出7.7%
5.6%
自由现金流更多
LNTH
多$238.5M
$-157.1M
两年增速更快
LNTH
近两年复合增速
-9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $273.0M | $406.8M |
| 净利润 | $15.4M | $54.1M |
| 毛利率 | 20.1% | 59.2% |
| 营业利润率 | 7.6% | 19.0% |
| 净利率 | 5.6% | 13.3% |
| 营收同比 | 9.0% | 4.0% |
| 净利润同比 | -6.7% | 558.8% |
| 每股收益（稀释后） | $0.30 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FORLNTH
| Q4 25 | $273.0M | $406.8M | ||
| Q3 25 | $670.5M | $384.0M | ||
| Q2 25 | $390.5M | $378.0M | ||
| Q1 25 | $351.0M | $372.8M | ||
| Q4 24 | $250.4M | $391.1M | ||
| Q3 24 | $551.3M | $378.7M | ||
| Q2 24 | $318.4M | $394.1M | ||
| Q1 24 | $333.8M | $370.0M |
净利润FORLNTH
| Q4 25 | $15.4M | $54.1M | ||
| Q3 25 | $86.9M | $27.8M | ||
| Q2 25 | $32.9M | $78.8M | ||
| Q1 25 | $31.6M | $72.9M | ||
| Q4 24 | $16.5M | $-11.8M | ||
| Q3 24 | $81.5M | $131.1M | ||
| Q2 24 | $38.7M | $62.1M | ||
| Q1 24 | $45.0M | $131.1M |
毛利率FORLNTH
| Q4 25 | 20.1% | 59.2% | ||
| Q3 25 | 22.3% | 57.9% | ||
| Q2 25 | 20.4% | 63.8% | ||
| Q1 25 | 22.6% | 63.8% | ||
| Q4 24 | 22.0% | 63.5% | ||
| Q3 24 | 23.9% | 63.9% | ||
| Q2 24 | 22.5% | 64.9% | ||
| Q1 24 | 24.9% | 65.4% |
营业利润率FORLNTH
| Q4 25 | 7.6% | 19.0% | ||
| Q3 25 | 16.9% | 11.4% | ||
| Q2 25 | 11.2% | 23.3% | ||
| Q1 25 | 11.6% | 27.4% | ||
| Q4 24 | 8.7% | 29.1% | ||
| Q3 24 | 19.7% | 35.3% | ||
| Q2 24 | 16.2% | 26.1% | ||
| Q1 24 | 17.6% | 28.8% |
净利率FORLNTH
| Q4 25 | 5.6% | 13.3% | ||
| Q3 25 | 13.0% | 7.2% | ||
| Q2 25 | 8.4% | 20.8% | ||
| Q1 25 | 9.0% | 19.6% | ||
| Q4 24 | 6.6% | -3.0% | ||
| Q3 24 | 14.8% | 34.6% | ||
| Q2 24 | 12.2% | 15.8% | ||
| Q1 24 | 13.5% | 35.4% |
每股收益（稀释后）FORLNTH
| Q4 25 | $0.30 | $0.86 | ||
| Q3 25 | $1.70 | $0.41 | ||
| Q2 25 | $0.65 | $1.12 | ||
| Q1 25 | $0.62 | $1.02 | ||
| Q4 24 | $0.32 | $-0.18 | ||
| Q3 24 | $1.59 | $1.79 | ||
| Q2 24 | $0.76 | $0.88 | ||
| Q1 24 | $0.89 | $1.87 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $359.1M |
| 总债务越低越好 | $793.2M | $568.7M |
| 股东权益账面价值 | $1.8B | $1.1B |
| 总资产 | $3.2B | $2.2B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.52× |
8季度趋势，按日历期对齐
现金及短期投资FORLNTH
| Q4 25 | $211.7M | $359.1M | ||
| Q3 25 | $379.2M | $382.0M | ||
| Q2 25 | $189.2M | $695.6M | ||
| Q1 25 | $174.3M | $938.5M | ||
| Q4 24 | $132.0M | $912.8M | ||
| Q3 24 | $481.2M | $866.4M | ||
| Q2 24 | $359.2M | $757.0M | ||
| Q1 24 | $416.2M | $718.3M |
总债务FORLNTH
| Q4 25 | $793.2M | $568.7M | ||
| Q3 25 | $802.7M | $567.9M | ||
| Q2 25 | $872.8M | $566.8M | ||
| Q1 25 | $872.5M | $566.1M | ||
| Q4 24 | $806.8M | $565.3M | ||
| Q3 24 | $706.4M | $613.0K | ||
| Q2 24 | $706.1M | $563.2M | ||
| Q1 24 | $705.7M | $562.5M |
股东权益FORLNTH
| Q4 25 | $1.8B | $1.1B | ||
| Q3 25 | $1.8B | $1.1B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.6B | $1.2B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.5B | $1.0B | ||
| Q1 24 | $1.5B | $945.5M |
总资产FORLNTH
| Q4 25 | $3.2B | $2.2B | ||
| Q3 25 | $3.1B | $2.3B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.1B | ||
| Q4 24 | $3.0B | $2.0B | ||
| Q3 24 | $2.8B | $2.0B | ||
| Q2 24 | $2.7B | $1.9B | ||
| Q1 24 | $2.6B | $1.8B |
负债/权益比FORLNTH
| Q4 25 | 0.44× | 0.52× | ||
| Q3 25 | 0.45× | 0.51× | ||
| Q2 25 | 0.52× | 0.49× | ||
| Q1 25 | 0.53× | 0.49× | ||
| Q4 24 | 0.50× | 0.52× | ||
| Q3 24 | 0.44× | 0.00× | ||
| Q2 24 | 0.47× | 0.55× | ||
| Q1 24 | 0.48× | 0.59× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $90.2M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $81.4M |
| 自由现金流率自由现金流/营收 | -57.5% | 20.0% |
| 资本支出强度资本支出/营收 | 0.0% | 2.2% |
| 现金转化率经营现金流/净利润 | -10.19× | 1.67× |
| 过去12个月自由现金流最近4个季度 | $93.0M | $354.1M |
8季度趋势，按日历期对齐
经营现金流FORLNTH
| Q4 25 | $-157.0M | $90.2M | ||
| Q3 25 | $256.3M | $105.3M | ||
| Q2 25 | $15.8M | $87.1M | ||
| Q1 25 | $-19.8M | $107.6M | ||
| Q4 24 | $-450.0M | $157.7M | ||
| Q3 24 | $119.2M | $175.1M | ||
| Q2 24 | $-61.7M | $84.7M | ||
| Q1 24 | $-59.2M | $127.2M |
自由现金流FORLNTH
| Q4 25 | $-157.1M | $81.4M | ||
| Q3 25 | $255.6M | $94.7M | ||
| Q2 25 | $15.0M | $79.1M | ||
| Q1 25 | $-20.5M | $98.8M | ||
| Q4 24 | — | $141.4M | ||
| Q3 24 | $118.4M | $159.3M | ||
| Q2 24 | $-62.3M | $73.5M | ||
| Q1 24 | $-59.8M | $119.0M |
自由现金流率FORLNTH
| Q4 25 | -57.5% | 20.0% | ||
| Q3 25 | 38.1% | 24.7% | ||
| Q2 25 | 3.8% | 20.9% | ||
| Q1 25 | -5.8% | 26.5% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | 21.5% | 42.0% | ||
| Q2 24 | -19.6% | 18.7% | ||
| Q1 24 | -17.9% | 32.2% |
资本支出强度FORLNTH
| Q4 25 | 0.0% | 2.2% | ||
| Q3 25 | 0.1% | 2.8% | ||
| Q2 25 | 0.2% | 2.1% | ||
| Q1 25 | 0.2% | 2.3% | ||
| Q4 24 | 0.0% | 4.2% | ||
| Q3 24 | 0.1% | 4.2% | ||
| Q2 24 | 0.2% | 2.8% | ||
| Q1 24 | 0.2% | 2.2% |
现金转化率FORLNTH
| Q4 25 | -10.19× | 1.67× | ||
| Q3 25 | 2.95× | 3.79× | ||
| Q2 25 | 0.48× | 1.11× | ||
| Q1 25 | -0.63× | 1.47× | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | 1.34× | ||
| Q2 24 | -1.59× | 1.36× | ||
| Q1 24 | -1.32× | 0.97× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
